Wound healing stack. BPC-157 for angiogenesis, LL-37 for antimicrobial protection.
The combination of BPC-157 and LL-37 represents a multi-pathway approach to biological age reduction. By simultaneously targeting distinct hallmarks of aging, this protocol achieves results that exceed the sum of its individual components.
BPC-157 primarily acts via upregulates vegfr2 to promote angiogenesis and activates the fak-paxillin pathway for accelerated tissue repair., while LL-37 complements this by human cathelicidin antimicrobial peptide that disrupts bacterial membranes, modulates tlr signaling, and promotes wound healing.. Together, they create a comprehensive cellular environment optimized for longevity and resilience.
BPC-157 Targets
LL-37 Targets
Systemic effectsStart This Protocol
Alukard provides physician-supervised longevity protocols, including the BPC-157 + LL-37 stack, with GMP-certified compounds and comprehensive biomarker testing.
Get Physician ConsultationBegin Your Age Reversal Protocol for BPC-157 + LL-37 Stack
Alukard provides physician-supervised longevity protocols with GMP-certified compounds, biomarker testing, and personalized biological age reduction programs.
HIPAA Compliant · GMP Certified · Physician Supervised · Biomarker Testing